Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PorA subtype P1.4 is a structurally distinct variant of an essential Neisserial porin that serves both physiological roles as a channel protein and critical pathogenic functions through interaction with host immunity—including being one of the main targets for protective vaccine-induced antibody responses against serogroup B N.meningitidis infections.
Antibody-mediated complement activation and bacterial killing
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer Membrane Porin Protein PorA P1.4 (PorA P1.4).